Clinical Trial Update: Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in children with Down syndrome to optimize spectacle prescriptions for refractive error correction and improved visual acuity; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Snippet

Sponsor: Ohio State University | Conditions: Refractive Error Correction, Visual Acuity | Phase 2 | Status: NOT_YET_RECRUITING